Trisomy 8 is Associated with Favorable Outcome in the Patients with Myelodysplastic Syndromes Treated with Allogeneic Hematopoietic Stem Cell Transplantation
DOI:
https://doi.org/10.12974/2312-5411.2022.09.04%20Keywords:
Myelodysplastic syndromes, Trisomy 8, Anti-apoptotic proteins, Hematopoietic stem cell transplantation, Favorable outcomeAbstract
Favorable prognostic significance of sole trisomy 8 and its associations with additional chromosome aberrations was confirmed in 7 adult and 3 pediatric patients with myelodysplastic syndromes treated with hematopoietic stem cell transplantation (HSCT). The group of comparison included 10 MDS patients with sole monosomy 7 or 5 chromosome and those within complex karyotypes (CK). Cytogenetic investigations were carried out according to standard GTG and multi-colored fluorescence in situ hybridization (mFISH) techniques. Our data revealed significant difference in overall survival (OS) between the tested and control groups (p=0.045) thus being additional argument reinforcing the concept of favorable prognosis of trisomy 8 in HSCT-treated MDS patients. Eight of ten patients (5 with sole trisomy 8 and three with more complex karyotypes) are alive. Of the deceased patients, one had CK trisomy 8 was associated with poor-prognostic monosomy 7. In accordance with experimental findings Sloand et al., 2007, this favorable effect of trisomy 8 in MDS patients might be linked with inhibition of programmed cell death with anti-apoptotic proteins, including myc, which are activated in these cases and needs additional in-depth studies.
References
Konuma T, Miyazaki Y, Uchida N, Ohashi K, Kondo T, Nakamae H, et al. Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Myelodysplastic Syndrome Harboring Trisomy 8. Biol Blood Marrow Transplant. 2017; 23(1): 75-80. https://doi.org/10.1016/j.bbmt.2016.10.015
Latypova MV, Mamaev NN, G indina TL, Shakirova AI, Paina OV, Osipova AA, et al. Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Myelodysplastic Syndromes with Trisomy 8 and/or Monosomy 7. Clin. Oncohematology. 2022: 15(2): 198-204. (In Russ), https://doi.org/10.21320/2500-2139-2022-15-2-198-204
Latypova MV, Mamaev NN, Gracheva TYu, Gindina TL. Cytogenetic Characteristic of Complex Karyotypes by Multicolor FISH in Myelodysplastic Syndromes and Associated Acute Myeloid Leukemias. Clin. Oncohematology 2022; 15(4): 396-413 (In Russ). https://doi.org/10.21320/2500-2139-2022-15-4-396-413
Sloand EM, Pfannes L, Chen G, Shah S. Solomou EE, Barrett J, and. Young NS. CD34 cells from patients with trisomy 8 myelodysplastic syndrome (MDS) express early apoptotic markers but avoid programmed cell death by up- regulation of antiapoptotic proteins. Blood 2007; 109: 23992405. https://doi.org/10.1182/blood-2006-01-030643